Routine Antigen Testing Is Not a Substitute for Health Care Worker Vaccination against SARS-CoV-2
The utility of rapid antigen testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is measured within the context for which it is applied; diagnostic accuracy must be considered in determining if rapid antigen testing is appropriate for the clinical situation. In this issue of the...
Saved in:
Published in | Journal of clinical microbiology Vol. 59; no. 11; p. e0156421 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
1752 N St., N.W., Washington, DC
American Society for Microbiology
19.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The utility of rapid antigen testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is measured within the context for which it is applied; diagnostic accuracy must be considered in determining if rapid antigen testing is appropriate for the clinical situation. In this issue of the
Journal of Clinical Microbiology
, J.
The utility of rapid antigen testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is measured within the context for which it is applied; diagnostic accuracy must be considered in determining if rapid antigen testing is appropriate for the clinical situation. In this issue of the
Journal of Clinical Microbiology
, J. N. Kanji, D. T. Proctor, W. Stokes, B. M. Berenger, et al. (J Clin Microbiol 59:e01411-21, 2021,
https://doi.org/10.1128/JCM.01411-21
) evaluate two rapid antigen tests that demonstrate high false-positive rates in asymptomatic health care workers. The assays may not be useful in situations where there is a shortage of staff, such as health care settings, since isolation would occur unnecessarily for these employees. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Citation Sexton ME, Kraft CS. 2021. Routine antigen testing is not a substitute for health care worker vaccination against SARS-CoV-2. J Clin Microbiol 59:e01564-21. https://doi.org/10.1128/JCM.01564-21. For the article discussed, see https://doi.org/10.1128/JCM.01411-21. |
ISSN: | 0095-1137 1098-660X 1098-660X |
DOI: | 10.1128/JCM.01564-21 |